Skip to main content

Table 2 Frequency distributions for the presence of eyeworms after treatment in both groups of animals

From: Efficacy of a formulation of sarolaner/moxidectin/pyrantel (Simparica Trio®) for the prevention of Thelazia callipaeda canine eyeworm infection

Treatment group

Eyeworms

Total

Negative

Positive

 

n

%

n

%

n

%

G1 (Simparica)

42

72.4

16

27.6

58

100

G2 (Simparica Trio)

58

100

0

0

58

100

  1. n: number of dogs, %: percentage of all dogs
Back to article page